Citations

Clear

4564 citation(s) found for "Yu, Virginia".

Acute exogenous oestradiol augments endothelial and smooth muscle vasodilatory responsiveness in premenopausal but not postmenopausal females
Dillon, Gabrielle A. , Limberg, Jacqueline K. , Nicholson, Wayne T. , Joyner, Michael J. , Baker, Sarah E. , Miller, Virginia M. , Ranadive, Sushant M. , Harvey, Ronée E , Limberg, Jacqueline K , Nicholson, Wayne T , Joyner, Michael J , Baker, Sarah E , Harvey, Ronée E.

Mayo Clinic

The Journal of Physiology | March 11, 2025 | Volume: 603 | Issue: 8 | Pages: 2301-2311

10.1113/jp287719 | PMID 40012199 Get It

AbstractMenopause is associated with vascular dysfunction. During the menopausal transition, endogenous oestradiol concentrations diminish. Oestradiol is vasoprotective because it has direct and indirect effects on the vasculature. The present study aimed to determine the effect of acute exogenous oestradiol on endothelium‐dependent, endothelium independent and β2‐adrenergic receptor‐induced vasodilatation in females. Forearm blood flow (venous occlusion plethysmography) was measured during brachial intraarterial infusions of ACh (endothelium‐dependent agonist), sodium nitroprusside (endothelium independent agonist) and terbutaline (β2‐adrenergic receptor agonist) with and without concurrent infusion of 17β‐oestradiol. Nine young premenopausal (age: 26 ± 4 years) and nine postmenopausal (PM, age: 58 ± 4 years, 8 ± 1 years post‐menopause) females completed the study. Concurrent oestradiol infusion augmented the vasodilatory response to ACh, sodium nitroprusside and terbutaline in young premenopausal (all P < 0.05) but not older postmenopausal (all P > 0.05), females. Local infusion of exogenous 17β‐oestradiol augmented endothelial and smooth muscle microvascular vasodilatation in premenopausal but not postmenopausal, females. imageKey points Menopause is associated with vascular dysfunction. Because oestradiol has vasoprotective effects, the menopause‐associated drop in oestradiol concentrations is hypothesized to contribute to vascular dysfunction during the menopause transition. The present study shows that local infusion of exogenous oestradiol augmented microvascular vasodilatation in premenopausal but not postmenopausal females.
Definitions, diagnosis, and management of postoperative recurrence in Crohn’s disease patients with permanent ileostomy—a systematic review and meta-analysis
Abushamma, Suha , Yadete, Tesfaye , Nero, Neil , Falloon, Katherine , Parker, Claire E. , Ahuja, Vineet, Armuzzi, Alessandro , Bemelman, Willem A. , Bruining, David H. , Feagan, Brian G. , Hart, Ailsa, Leong, Rupert W. , Narula, Neeraj , Raine, Tim , Singh, Siddharth , Sparrow, Miles , Spinelli, Antonino , Koughnett, Julie Ann Van, Solitano, Virginia , Yuan, Yuhong , Rieder, Florian , Deepak, Parakkal , Dignass, Axel , Fulmer, Clifton , Halfvarson, Jonas , Holubar, Stefan D , Ma, C , Magro, F , McCurdy, Jeffrey D , Narula, Neeraj , Panes, Julian , Raine, Tim , Regueiro, Miguel , Spinelli, Antonino , Rieder, Florian , Solitano, Virginia , Leong, Rupert W , Abreu, María T. , Ahuja, Vineet , Deepak, Parakkal , Dotan, Iris , Fulmer, Clifton G. , Hart, Ailsa , Holubar, Stefan D. , Ma, Christopher , Magro, Fernando , Panés, Julián , Regueiro, Miguel , Rogler, Gerhard , Vuyyuru, Sudheer K. , Jairath, Vipul

Mayo Clinic

Journal of Crohn's and Colitis | March 11, 2025 | Volume: 19 | Issue: 4 | Pages: No page available

10.1093/ecco-jcc/jjaf041 | PMID 40066499 Get It

Abstract Background and Aims Over 10% of patients with Crohn’s disease require permanent ileostomy. We aimed to summarize the existing data on diagnosis, definitions of recurrence, and management of Crohn’s disease patients with permanent ileostomy. Methods MEDLINE, Embase, and CENTRAL databases were searched from inception to February 6, 2024. Randomized controlled trials, cohort and cross-sectional studies, and case series of more than 5 patients reporting on postoperative recurrence or the need for surgery in patients with Crohn’s disease and permanent ileostomy were included. Search results were independently screened, and full text of all titles meeting eligibility criteria was obtained. Outcomes of interest included diagnostic techniques, recurrence definitions, and management approaches. We estimated pooled rates (with 95% confidence interval [CI]) of recurrence. Results Thirty cohort studies including 2055 Crohn’s patients with permanent ileostomy were included (53% female, median age at the time of ileostomy creation 32 years, the most common reason for ileostomy was refractory disease). The postoperative recurrence rate was 27% (95% CI, 21.3–33.3, 26 studies, 451/1805 patients). Modalities for diagnosis of Crohn’s disease recurrence were symptoms (15 studies), endoscopy (4 studies), histology from endoscopic biopsies (2 studies), imaging (5 studies), and surgery (22 studies). The reported definitions of recurrence for each modality were heterogeneous. Conclusions There is a lack of standardized monitoring tools and criteria for diagnosing recurrence in patients with Crohn’s disease and permanent ileostomy. The results of this systematic review will form the basis of a global expert recommendation exercise focused on developing management standards and trial endpoints for this condition.
Remedying Black cancer disparities with clinical research prioritization
Ashing, Kimlin , Barrett, Nadine J. , Rhoads, Kim F. , Thompson, Hayley , Ragin, Camille , Thompson, Hayley S. , Ashing, Kimlin Tam , Barrett, Nadine , Nolan, Timiya S. , Sheppard, Vanessa B.

Mayo Clinic

Cancer | March 10, 2025 | Volume: 131 | Issue: 6 | Pages: No page available

10.1002/cncr.35785 | PMID 40045662 Get It

Community Outreach and Engagement (COE) ought to be prioritized, resourced, and supported to appropriately fulfill the Cures Act and tackle Catchment Community cancer burden and disparities. COE is not a person but the vision of community/public cancer prevention and control that surpasses both political and institutional leaders.
Why do people still make anti‐D over 50 years after the introduction of Rho(D) immune globulin? A Biomedical Excellence for Safer Transfusion (BEST) Collaborative study
DelBaugh, Regina M. , Murphy, Michael , Staves, Julie , Fachini, Roberta , Hands, Katie , Bub, Carolina Bonet , Cohn, Claudia S. , Cox, Cody A., Ziman, Alyssa , Fermon, Erica J., Peters, Jessica, Collaborative, BEST foRmation of Anti‐D After Rhogam (RADAR) Study Investigators and the Biomedical Excellence for Safer Transfusion (BEST), Callum, Jeannie , Murphy, Michael , Wendel, Silvano , Bonet-Bub, Carolina , Cohn, Claudia S , Jacquot, Cyril , Hasan, Rida A , Lu, Wen , Juskewitch, Justin E , Raval, Jay S , Fung, Mark K , Ziman, Alyssa , Dunbar, Nancy M , Kutner, José Mauro , Cox, Cody A., Jacquot, Cyril , Hasan, Rida A. , Lu, Wen , Juskewitch, Justin E. , Raval, Jay S. , Rollins‐Raval, Marian A. , Gorlin, Jed B. , Dunbar, Nancy M. , Collaborative, BEST foRmation of Anti‐D After Rhogam (RADAR) Study Investigators and the Biomedical Excellence for Safer Transfusion (BEST)

Mayo Clinic

Transfusion | March 10, 2025 | Volume: 65 | Issue: 5 | Pages: 957-967

10.1111/trf.18202 | PMID 40059673 Get It

Abstract Background Rho(D) immune globulin (RhIg) is used to reduce RhD alloimmunization in pregnancy. This study describes potential causes for RhD alloimmunization after the development and implementation of RhIg. Study Design and Methods This retrospective descriptive study investigated RhD‐negative patients born in 1965–2005 with anti‐D newly identified during 2018–2022. Transfusion, pregnancy, intravenous drug abuse, and transplantation were considered potential alloimmunization sources. Results There were 1200 study patients (852 females; 348 males) at 30 institutions in 5 countries (USA, Canada, UK, New Zealand, Brazil). Most patients had a single potential source of alloimmunization identified (857/1200, 71%), most commonly pregnancy among females (537/852, 63%) and transfusion among males (180/348, 52%). When multiple potential sources were included, males were more likely than females to have a history of transfusion (235/348 [68%] vs. 149/852 [17%], p < .0001) and confirmed or suspected intravenous drug abuse (100/348 [29%] vs. 138/852 [16%], p < .0001). Among females with a history of pregnancy, 119/718 (17%) had healthcare access issues, 120/718 (17%) had pregnancy in a country where they may not have received RhIg, and 21/718 (3%) refused RhIg. Among patients with a history of transfusion, males were more likely than females to have received RhD‐positive red blood cells or whole blood (143/235 [61%] vs. 30/149 [20%], p < .0001) and/or platelets (84/235 [36%] vs. 19/149 [13%], p < .0001). Discussion Pregnancy was the most frequently identified potential source of RhD alloimmunization among females. Transfusion was most frequent in males. Intravenous drug abuse as a common potential source among patients with RhD alloimmunization merits further study.
Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge
LaBella, Dominic , Baid, Ujjwal , Khanna, Omaditya , McBurney-Lin, Shan , McLean, Ryan, Rashid, Arif , Altes, Talissa A. , Bhalerao, Radhika , Dhemesh, Yaseen , Hilal, Fathi , Janas, Anastasia , Kazerooni, Anahita Fathi , Kent, Collin , Leu, Kevin , Maleki, Nazanin , Pajot, Maxence , Saluja, Rachit , Wang, Chunhao , Warman, Pranav , Adewole, Maruf , Albrecht, Jake, Anwar, Syed Muhammad , Bergquist, Timothy , Chen, Sully Francis, Conte, Gian-Marco, Eddy, J. Mark , Ezhov, Ivan , Jiang, Zhifan , Johanson, Elaine, Linguraru, Marius George , Liu, Xinyang , Meier, Zeke, Shinohara, Russell Takeshi, Abayazeed, Aly, Akinola, Rachel , Bilello, Michel , Verdier, Maria Correia de, Moassefi, Mana, Pease, Matthew W., Vollmuth, Phillipp, Diffley, David, Hussain, Ali , Fehringer, Pascal, Bronstein, Yulia, Deptula, Lisa, Stein, Evan G. , Taherzadeh, Mahsa , Oliveira, Eduardo Portela de, Haughey, Aoife , Kontzialis, Marinos , Saba, Luca , Turner, Benjamin , Brüßeler, Melanie, Gkampenis, Athanasios , Weiss, David Maximilian, Mansour, Aya, Shawali, Islam H., Yordanov, Nikolay , Hourani, Roula , Moshebah, Mohammed Yahya, Abouelatta, Ahmed Magdy, Willms, Klara, Martin, Dann C., Okar, Abdullah , Kite, Dominic , Haider, Muhammad Ammar , Aristizábal, Alejandro , Karargyris, Alexandros , Kassem, Hasan , Sheller, Micah , Alonso‐Basanta, Michelle , McLean, Ryan, Nedelec, Pierre , Rashid, Arif, Tahon, Nourel Hoda , Godfrey, Devon , Floyd, Scott , Kirkpatrick, John P. , Kofler, Florian , Menze, Bjoern H. , Reitman, Zachary J. , Rudie, Jeffrey D. , Velichko, Yury , Anazodo, Udunna , Chung, Verena , Chai, Rong, Dako, Farouk , Eddy, James, Khalili, Nastaran , Iglesias, Juan Eugenio , Leemput, Koen Van , Li, Hongwei , Mahtabfar, Aria , Moawad, Ahmed W. , Mongan, John , Piraud, Marie , Shinohara, Russell Taki , Wiggins, Walter F. , Jakab, András Áron , Verdier, Maria Correia de , Crivellaro, Priscila Sacilotto , Davatzikos, Christos , Farahani, Keyvan , Freymann, John , Hess, Christopher Paul , Huang, Raymond Y. , Lohmann, Philipp , Moassefi, Mana , Sollmann, Nico , Nandolia, Khanak , Warren, Daniel I, Saba, Luca , Ansari, Shehbaz , Stein, Joel M. , Rizvi, Tanvir , D’Anna, Gennaro , Taha, Ahmed , Sharifi, Yasaman , Faghani, Shahriar , Pinho, Marco C. , Pati, Sarthak , Villanueva-Meyer, Javier E. , Rauschecker, Andreas M. , Nada, Ayman , Aboian, Mariam , Flanders, Adam E , Wiestler, Benedikt , Bakas, Spyridon , Calabrese, Evan

Mayo Clinic

Machine Learning for Biomedical Imaging | March 7, 2025 | Volume: 3 | Issue: March 2025 | Pages: 38-58

10.59275/j.melba.2025-bea1 Get It

We describe the design and results from the BraTS 2023 Intracranial Meningioma Segmentation Challenge. The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in that it focused on meningiomas, which are typically benign extra-axial tumors with diverse radiologic and anatomical presentation and a propensity for multiplicity. Nine participating teams each developed deep-learning automated segmentation models using image data from the largest multi-institutional systematically expert annotated multilabel multi-sequence meningioma MRI dataset to date, which included 1000 training set cases, 141 validation set cases, and 283 hidden test set cases. Each case included T2, FLAIR, T1, and T1Gd brain MRI sequences with associated tumor compartment labels delineating enhancing tumor, non-enhancing tumor, and surrounding non-enhancing FLAIR hyperintensity. Participant automated segmentation models were evaluated and ranked based on a scoring system evaluating lesion-wise metrics including dice similarity coefficient (DSC) and 95% Hausdorff Distance. The top ranked team had a lesion-wise median dice similarity coefficient (DSC) of 0.976, 0.976, and 0.964 for enhancing tumor, tumor core, and whole tumor, respectively and a corresponding average DSC of 0.899, 0.904, and 0.871, respectively. These results serve as state-of-the-art benchmarks for future pre-operative meningioma automated segmentation algorithms. Additionally, we found that 1286 of 1424 cases (90.3%) had at least 1 compartment voxel abutting the edge of the skull-stripped image edge, which requires further investigation into optimal pre-processing face anonymization steps.
Macrophage peroxisomes guide alveolar regeneration and limit SARS-CoV-2 tissue sequelae
Wei, Xiaoqin , Qian, Wei , Narasimhan, Harish , Chan, T. K., Liu, Xue , Arish, Mohd , Young, Scott , Li, Chaofan , Cheon, In Su , Yu, Qing , Santos, Gislane de Almeida , Yeatts, Eric V., Spear, Olivia J., Yi, Mou, Hahn, Young S. , Kaplan, Mark H. , Sperling, Anne I. , Shim, Yun M. , Vassallo, Robert , Chen, Peter , Roden, Anja C. , Que, Jianwen , Chan, Ting , Young, Samuel , de Almeida Santos, Gislane , Zhao, Xiao-Yu , Yeatts, Eric V , Parimon, Tanyalak , Fang, Yinshan , Hahn, Young S , Bullock, Timothy N J , Somerville, Lindsay A , Kaplan, Mark H , Sperling, Anne I , Shim, Yun Michael , Vassallo, Robert , Chen, Peter , Ewald, Sarah E , Roden, Anja C , Que, Jianwen , Jiang, Dianhua , Sun, Jie , Li, Chaofan , Yi, Megan, Somerville, Lindsay , Sun, Jie

Mayo Clinic

Science | March 6, 2025 | Volume: 387 | Issue: 6738 | Pages: No page available

10.1126/science.adq2509 | PMID 40048515 Get It

Peroxisomes are vital but often overlooked metabolic organelles. We found that excessive interferon signaling remodeled macrophage peroxisomes. This loss of peroxisomes impaired inflammation resolution and lung repair during severe respiratory viral infections. Peroxisomes were found to modulate lipid metabolism and mitochondrial health in a macrophage type-specific manner and enhanced alveolar macrophage-mediated tissue repair and alveolar regeneration after viral infection. Peroxisomes also prevented excessive macrophage inflammasome activation and IL-1β release, limiting accumulation of KRT8 high dysplastic epithelial progenitors following viral injury. Pharmacologically enhancing peroxisome biogenesis mitigated both acute symptoms and post-acute sequelae of COVID-19 (PASC) in animal models. Thus, macrophage peroxisome dysfunction contributes to chronic lung pathology and fibrosis after severe acute respiratory syndrome coronavirus 2 infection.
Minimal clinical impact of embolization to new territory on outcomes in medium vessel occlusion strokes treated with mechanical thrombectomy: a retrospective multicenter study
Salim, Hamza , Yedavalli, Vivek , Lakhani, Dhairya A. , Milhem, Fathi , Musmar, Basel , Adeeb, Nimer , Faizy, Tobias D. , Daraghma, Motaz , Naamani, Kareem El, Henninger, Nils , Sundararajan, Sri Hari , Khalife, Jane , Grewal, Inayat , Tan, Benjamin Yong‐Qiang , Regenhardt, Robert W. , Heit, Jeremy J. , Puri, Ajit S., Dyzmann, Christian , Filipe, João Pedro , Abdalkader, Mohamad , Marotta, Thomas R. , Spears, Julian , Jabbour, Pascal , Biswas, Arundhati , Clarençon, Frédéric, Varela, Ricardo , Baker, Amanda , Altschul, David , Gonzalez, Nestor R. , Möhlenbruch, Markus , Costalat, Vincent , Stracke, Christian Paul , Shaikh, Hamza , Liebeskind, David S. , Alexandre, Andrea , Tancredi, Illario , Kalsoum, Erwah , Lubicz, Boris , Patel, Aman B. , Guenego, Adrien , Salim, Hamza , Ghozy, Sherief , Scarcia, Luca , Yeo, Leonard Ll , Cancelliere, Nicole M , Rouchaud, Aymeric , Fiehler, Jens , Sheth, Sunil A , Colasurdo, Marco , Alexandru Radu, Răzvan , Klein, Piers , Ota, Takahiro , Jabbour, Pascal , Siegler, James E , Nguyen, Thanh N , Essibayi, Muhammed Amir , Altschul, David J , Gonzalez, Nestor R , Hecker, Constantin , Marnat, Gaultier , Shaikh, Hamza A , Griessenauer, Christoph J , Liebeskind, David S. , Alexandre, Andrea M , Kalsoum, Erwah , Mendes Pereira, Vitor , Guenego, Adrien , Dmytriw, Adam A , Heit, Jeremy J , Musmar, Basel , Regenhardt, Robert W , Lakhani, Dhairya , Yedavalli, Vivek S , Henninger, Nils , Tan, Benjamin Yq , Varela, Ricardo , Naamani, Kareem El , Kühn, Anna Luisa , Ghozy, Sherief , Cancelliere, Nicole M , Rouchaud, Aymeric , Fiehler, Jens , Puri, Ajit S , Colasurdo, Marco , Renieri, Leonardo , Harker, Pablo , Radu, Răzvan Alexandru , Klein, Piers , Mowla, Ashkan , Clarençon, Frédéric , Siegler, James E. , Nguyen, Thanh N. , Essibayi, Muhammed Amir , Gory, Benjamin , Hecker, Constantin , Griessenauer, Christoph J. , Pedicelli, Alessandro , Wintermark, Max , Dmytriw, Adam A.

Mayo Clinic

Journal of NeuroInterventional Surgery | March 5, 2025 | Volume: 18 | Issue: 1 | Pages: 186-194

10.1136/jnis-2024-022570 | PMID 40044412 Get It

Background Mechanical thrombectomy (MT) is established as an effective treatment for large vessel occlusion strokes, but its efficacy and safety for medium vessel occlusions (MeVOs) remain less clear. This study examines the impact of periprocedural embolization to a new vascular territory (ENT) on clinical outcomes in patients with MeVO stroke treated with MT. Methods A multicenter, retrospective analysis was conducted using the MAD-MT (Multicenter Analysis of primary Distal medium vessel occlusions: effect of Mechanical Thrombectomy) registry, including 2122 patients with MeVO stroke w­ho underwent MT between September 2017 and July 2023. ENT was defined as filling defects in previously unaffected territories, excluding embolization near the original occlusion, observed on final angiographic runs after retrieval of the primary thrombus. The associations between ENT, procedural variables, and 90-day clinical outcomes were evaluated, including functional independence (modified Rankin Scale (mRS) scores of 0–2), excellent outcomes (mRS 0–1), mortality, and hemorrhagic complications. Results ENT occurred in 2.9% (63/2122) of patients. Longer onset-to-arterial puncture time (adjusted OR 1.03; 95% CI 1.01 to 1.05; P=0.002) and a greater number of passes (adjusted OR 1.15; 95% CI 1.01 to 1.32; P=0.032) were associated with increased ENT risk, while excellent recanalization (thrombolysis in cerebral infarction (TICI) scale score 2c–3) was associated with reduced ENT risk (adjusted OR 0.41; 95% CI 0.23 to 0.72; P=0.002). ENT was not associated with poorer functional independence, mortality, or hemorrhagic complications. Conclusions ENT during MT for MeVO stroke occurs infrequently and does not significantly affect the clinical outcomes. These findings suggest ENT risk should not deter clinicians from performing MT in patients with MeVO. Further prospective studies are needed to validate these results.
Recommendations for use of extracorporeal shockwave therapy in sports medicine: an international modified Delphi study
Singh, Mani, Maffulli, Nicola , Saxena, Amol , Leal, Carlos , Gerdesmeyer, Ludger , Quirologico, Kristina, Furia, John P. , Zwerver, Johannes , Huang, Shih‐Wei , Jarnagin, Johnny, Ruiz, Joseph C. , Noble-Taylor, Kayle E, Al-Khawashki, Hazem , Blatz, Brice W., Borg‐Stein, Joanne , Borowski, Lauren , Bowen, Jay E., Chin, Michael D. , Conenello, Robert M, Fredericson, Michael , Fullem, Brian, Hollander, Karsten , Jelsing, Elena J., Langer, Paul R., Meron, Adele, Monaco, Robert, Paul, Rowan V, Raiser, Sara , Ratcliff, James W, Sampson, Steven , Schaden, Wolfgang , Spector, Jay, Sun, Wei , Syrop, Isaac P., Takahashi, Kenji, Tan, Benedict , Wyss, James F. , Zin, Dan, Hoo, Jennifer Soo , Tenforde, Adam S. , Maffulli, Nicola , Saxena, Amol , Liao, Chun-De , Moya, Daniel , Fredericson, Michael , Hollander, Karsten , Raiser, Sara , Tenforde, Adam S , Rhim, Hye Chang , Robinson, David M. , Ruiz, Joseph, Noble-Taylor, Kayle E., Chin, Michael, Conenello, Robert M., Silbernagel, Karin Grävare , Mautner, Kenneth , Paul, Rowan V, Spector, Jay

Mayo Clinic

British Journal of Sports Medicine | March 3, 2025 | Volume: 59 | Issue: 18 | Pages: 1287-1301

10.1136/bjsports-2024-109082 | PMID 40032293 Get It

Objectives While extracorporeal shockwave therapy (ESWT) may be an efficacious adjunctive treatment option for musculoskeletal injuries, current research is limited by significant heterogeneity within treatment protocols. This study aims to establish international expert consensus recommendations on ESWT terminology, parameters, procedural considerations, contraindications and side effects in the application of ESWT to sports injuries. Methods A systematic literature search was performed on the use of ESWT for musculoskeletal and sports medicine injuries to identify potential panellists, followed by the development of a steering committee-led questionnaire. A three-stage, modified Delphi questionnaire was provided to a panel of 41 international clinical and research experts across 13 countries. Panellists had the opportunity to suggest edits to existing statements or recommend additional statements in Round 1. Consensus was defined as≥75% agreement. Results All 41 panellists completed Rounds 1, 2 and 3. Consensus was reached on 69/118 statements (58.5%), including recommendations on terminology and fundamental concepts, indications for use, procedural aspects for tendinopathy and bone pathologies, treatment correlations with imaging, periprocedural and postprocedural considerations, absolute and relative contraindications and potential side effects. Of the 49 statements that did not reach consensus, 17/49 (34.7%) were related to procedural aspects of bone pathology. Conclusion This international panel presents recommendations on ESWT terminology, indications and treatment considerations to guide ESWT use and decision-making by sports medicine clinicians. While our panel supported the use of ESWT in the treatment of bone pathologies, certain procedural aspects of ESWT specific to these injuries did not reach consensus and require further investigation.
Urinary control in cervical myelopathy: does it improve postsurgery? A Quality Outcomes Database study
Shabani, Saman , Le, Vivian , Jamieson, Alysha, Chan, Andrew K. , Johnson, Sarah E. , Wang, Michael Y. , Haid, Regis W., Knightly, John J. , Gottfried, Oren N., Shaffrey, Christopher I. , Virk, Michael S. , Shaffrey, Mark E., Foley, Kevin T. , Coric, Domagoj , Upadhyaya, Cheerag D., Potts, Eric A. , Turner, Jay D. , Tumialán, Luis M. , Chou, Dean , Fu, Kai-Ming, Asher, Anthony L. , Bisson, Erica F. , Bydon, Mohamad , Mummaneni, Praveen V. , Lavadi, Raj Swaroop , Agarwal, Nitin , Letchuman, Vijay , Park, Paul , Uribe, Juan S.

Mayo Clinic

Journal of Neurosurgery: Spine | February 28, 2025 | Volume: 42 | Issue: 5 | Pages: 541-550

10.3171/2024.10.spine24338 | PMID 40020227 Get It

OBJECTIVE Cervical spondylotic myelopathy (CSM) can be associated with urinary dysfunction, leading to an inability or marked difficulty with micturition. This study aimed to evaluate the urinary dysfunction, long-term prognosis, and recovery in patients with CSM following surgical intervention. METHODS The CSM cases of the Quality Outcomes Database SpineCORe study group were analyzed. Urinary control was assessed using the modified Japanese Orthopaedic Association (mJOA) urinary function subscore. Improvement was defined as a minimum improvement of 1 point in the mJOA urinary function subscore at the 2-year follow-up. Univariate and multivariable analyses were conducted as appropriate. RESULTS Of 1141 patients, 772 (67.7%) patients were identified with a minimum 2-year follow-up mJOA score, and 249 (32.3%) of these patients reported baseline urinary dysfunction. Of those 249 patients with baseline urinary control problems, 193 (77.5%) had improvement in urinary function postoperatively, and more women than men had improved urinary control after CSM surgery (54.9% vs 45.1%, p = 0.03). Apart from sex, demographic characteristics of patients who experienced urinary function improvement versus those who did not were similar. Patients who experienced urinary function improvement had lower overall baseline mJOA scores (10.2 vs 13, p < 0.01). Both cohorts reported similar rates of postoperative satisfaction (North American Spine Society scores of 1 and 2) (89.1% vs 85.9%, p = 0.26). CONCLUSIONS Among the one-third of patients with CSM experiencing urinary dysfunction, nearly 78% achieve improved urinary function at the 2-year postoperative follow-up. Women are more likely to experience improvement in this function. Patients with and without improvements in urinary function are equally satisfied with their surgery and report similar outcomes on long-term follow-up.
Safe and efficacious therapeutic outcomes with salvage endonasal transsphenoidal surgery for pituitary adenoma progression following stereotactic radiosurgery
Shinya, Yuki , Hong, Sukwoo , Erickson, Dana , Wipplinger, Tamara , Palit, Sandhya R. , Shin, Masahiro , Link, Michael J. , Pollock, Bruce E., Atkinson, John L. D., Wipplinger, Christoph , Herndon, Justine S, Wipplinger, Tamara M, Shinya, Yuki , Hasegawa, Hirotaka , Bancos, Irina , Herndon, Justine , Shin, Masahiro, Saito, Nobuhito , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurosurgery | February 28, 2025 | Volume: 143 | Issue: 1 | Pages: 165-173

10.3171/2024.10.jns241682 | PMID 40020238 Get It

OBJECTIVE Stereotactic radiosurgery (SRS) offers excellent tumor control for pituitary adenoma (PA); however, treatment failure occasionally necessitates salvage surgery. Comprehensive studies on salvage surgical outcomes for recurrent PA after SRS remain scarce. This study aimed to elucidate the outcomes of salvage endonasal transsphenoidal surgery (sETS) for progressive PA failing SRS. METHODS This retrospective, two institution–based cohort study analyzed data from patients who underwent sETS for progressive PA failing SRS. Progression-free survival (PFS), disease-specific survival (DSS), and neurological and endocrinological outcomes in the sETS group were analyzed and compared with those in the primary ETS (pETS) group after propensity score matching using the following variables: age at surgery, maximum tumor diameter, highest Knosp–Steiner classification, and tumor type. RESULTS Thirteen sETS patients (8 males [62%], median age at surgery of 56 years) with 5 nonfunctioning (39%), 6 corticotropic (46%), and 2 other functioning (15%) PAs who received median (range) follow-up of 125 ( 23–169) months were included. None of the patients experienced new neurological deficits or death after sETS. The median (range) tumor resection rate was 90% (80%–100%). The 5-year PFS and DSS rates were 55% and 77%, respectively. All 4 patients (31%) who experienced recurrence after sETS had corticotropic tumors. In the matched cohort analysis between the sETS group with 12 patients and the pETS group with 12 patients, no significant differences were observed in surgical outcomes. PFS rates were marginally higher in the sETS group than in the pETS group (80% vs 49% at 3 years, p = 0.216, log-rank test), and DSS was similar between the two groups (p = 0.543, log-rank test). CONCLUSIONS The authors’ results indicate that ETS can be safely performed as a salvage treatment after failed SRS with low complication rates and satisfactory tumor control in treatment-resistant PA.